CAI, Fedegari Group Partner to Elevate Steam Sterilization Capabilities

CAI, a global provider of technical, operational consulting, and project management services, has partnered with Fedegari Group, a manufacturer and service provider of sterilization systems, to elevate steam sterilization capabilities for companies spanning the life sciences and biotech industries.
 
The goal of the partnership is to improve the application of steam sterilization science and minimize sterilization process implementation time, in order to reduce lifecycle costs, lower cost of goods, and streamline manufacturing processes.
 
According to the terms of the partnership, Fedegari and CAI will integrate their offerings to provide a seamless experience from procurement to operation. In addition, the partners will cooperate on developing and validating state-of-the-art sterilization technology, driving science-based sterilization processes, and protecting both sensitive products and process equipment.
 
“Fedegari is a world leader in providing aseptic manufacturing solutions, without operator intervention to produce advanced sterile products. As a strategic partner to the biotech and pharmaceutical industry, we resolve customer needs, thanks to our valuable expertise in sterilization and bio-decontamination processes. For this reason, we always pay close attention to technological innovation,” said Stefano Nanni, Fedegari’s General Manager. “Partnering with CAI is a significant step forward in our mission to introduce a groundbreaking sterilization technology to the world. Their support will be instrumental in accelerating this innovation.”
 
“In this unprecedented time of innovation for biopharma and biotech, operational excellence throughout each phase of manufacturing, especially in sterilization, is critical to effective manufacturing operations,” explained Alice Redmond, CAI’s Chief Strategy Officer. “Our partnership with Fedegari will empower companies to streamline operations and accelerate delivery of groundbreaking treatments to patients worldwide.”